Best of 2023: New Laboratory Insights for the ANA+ Consult A new study suggests that use of ELISA assays for CXCL-10 and IFN-α can predict which ANA+ individuals may progress to developing a systemic autoimmune rheumatic disease (SARD) https://t.co/5RgA143wLb https://t.co/JZU7ZX3Gty